Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of treating epithelial growth factor receptor (EGFR) T790M-positive non-small cell lung cancer by administering a combination of a VEGFR-2 antibody and osimertinib

Method of treating epithelial growth factor receptor (EGFR) T790M-positive non-small cell lung cancer by administering a combination of a VEGFR-2 antibody and osimertinib

US Patent 11471457 · Granted Oct 18, 2022

Estimated economic value: $706,477,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Apparatus and method for updating internet-based malware detection engine using 2025
Cooling medium circulation apparatus for vehicle2025
Composition for surface modification2025
Apparatus for treating substrate2025
Apparatus for treating substrate2025
Rear combination lamp for automobile2025
Apparatus for treating substrate and temperature control method2025
Delivery robot2025
Apparatus for treating substrate2025
Apparatus for treating substrate and method of coupling support unit2025
Apparatus and method for page allocation in many-to-one virtualization environme2025
V2X-based electronic toll collection system and method2025